Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Acon, Asahi Kasei, Eyeyon Medical, Fize Medical, Helio Genomics, Lunit, Olympus, SS Innovations, Staar.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Resmed.

The top 10 med-tech stock gainers and losers for the week.

The top 10 biopharma stock gainers and losers for the week.

These graphs compare the performance of the biotech stocks for all of 2025 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2025.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: J&D, Eli Lilly, Merakris, Uniqure.

Biopharma happenings, including deals and partnerships, and other news in brief: Alexion, Alzinova, Atossa, Astrazeneca, Formycon, Jyong, MS Pharma, Neurimmune, Orano, Propanc, Replicate, Roche, Sichuan Kelun, Vycellix.

Clinical updates, including data readouts and publications: Apellis, Bioage, Bioarctic, Estrella, Immvira, Pliant, Sobi.